PheoSeq
María Currás-Freixes(Spanish National Cancer Research Centre), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Timo Deutschbein(Klinikum Oldenburg), Juan C. Galofré(Instituto de Salud Pública de Navarra), María Apellániz-Ruiz(Navarrabiomed), Felix Beuschlein(University of Zurich), Martin Faßnacht(University of Würzburg), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Milagros Balbı́n(Hospital Universitario Central de Asturias), Paz de Miguel-Novoa(Hospital Clínico San Carlos), Fátima Al‐Shahrour(Broad Institute), Rafael Torres‐Pérez(Spanish National Cancer Research Centre), Natalie Rogowski-Lehmann(Ludwig-Maximilians-Universität München), Esther Korpershoek(Radboud University Nijmegen), Tonino Ercolino(Azienda Ospedaliero-Universitaria Careggi), Massimo Mannelli(University of Florence), Judith Balmaña-Gelpí(Vall d'Hebron Hospital Universitari), Giuseppe Opocher(University of Padua), Javier Aller(Hospital Universitario Puerta de Hierro Majadahonda), Sonsoles Guadalix(Research Institute Hospital 12 de Octubre), Juan María Roldán‐Romero(European Bioinformatics Institute), Bruna Calsina(Spanish National Cancer Research Centre), Elena Piñeiro-Yáñez(Spanish National Cancer Research Centre), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Cristina Lamas(Hospital General Universitario de Albacete), Ronald R. de Krijger(University Medical Center Utrecht), Karel Pacák(Endocrine Society), Xavier Matías‐Guiu(Universitat de Lleida), Conxi Lázaro(Institut d'Investigació Biomédica de Bellvitge), Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Laurent Vroonen(Centre Hospitalier Universitaire de Liège), Laura Remacha(Spanish National Cancer Research Centre), Stephanie Fliedner(University Hospital Schleswig-Holstein), Cristina Montero‐Conde(Spanish National Cancer Research Centre), Amparo Meoro-Avilés(Hospital Reina Sofía de Murcia), María Calatayud(Hospital Universitario 12 De Octubre), Alberto Cascón(Spanish National Cancer Research Centre), Susan Richter(University of Auckland), Ana Patiño‐García(Navarre Institute of Health Research), Júlia Sastre-Marcos(Hospital Virgen de la Salud), Rocío Letón
Cited by 77
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951